Book CD30 IHC Test | Lahalak Medical Platform
A key diagnostic tool for large cell lymphomas, guiding patients toward modern, targeted treatments that increase efficacy while significantly reducing potential side effects for a better recovery journey.
Scientific name: Immunohistochemistry (IHC) for CD30
Immunohistochemistry for the CD30 marker aims to detect the CD30 protein (a member of the Tumor Necrosis Factor receptor family). It is a distinguishing marker for activated cells, particularly for activated T-lymphocytes and large anaplastic B-cells. It is fundamental in diagnosing Classical Hodgkin Lymphoma (cHL) and Anaplastic Large Cell Lymphom...
Included Services
- Detailed analysis to detect CD30 protein expression in tissue samples
- Consultation on interpreting results with a pathologist
- Personal support services from Lehlek
Medical Service Information
Conditions & Notices
- Fasting is not required, as the sample is a tissue sample (biopsy).
- The biopsy specimen must be properly preserved in 10% formalin to maintain tissue antigens.
- Accompany complete clinical information regarding the sample site and symptoms to aid in accurate interpretation.
- Confirmation of the diagnosis may require further analytes (e.g., ALK for ALCL).